Industry News
Previously unknown effect of vitamin A identified
Feb 26, 2015
The signal molecule, retinoic acid, is a product of vitamin A which helps to instruct how different types of tissue are to be formed in the growing embryo. Read More
Castle Biosciences announces publication of esophageal cancer study
Feb 25, 2015
Castle Biosciences, Inc. has announced the publication of the second clinical validation study of its multi-analyte test for esophageal cancer. Read More
Clarithromycin as an anti-cancer agent
Feb 25, 2015
An antibiotic may join the ranks of drugs suitable for repurposing as anti-cancer treatments, according to new research from the Repurposing Drugs in Oncology (ReDO) project published in... Read More
'As long as it's safe, we need to encourage patients to go back to work', says pioneering cancer nurse
Feb 25, 2015
Returning to work can help cancer patients with their recovery from bone marrow (or stem cell) transplants, a new report by the blood cancer charity Anthony Nolan has revealed. Read More
Open access to large cancer datasets is critical to clinical advances
Feb 25, 2015
A major challenge facing cancer researchers is the identification and treatment of drug resistant cancers. Read More
Master gene regulatory pathway revealed as key target for therapy of aggressive pediatric brain cancer
Feb 25, 2015
Working with cells taken from children with a very rare but ferocious form of brain cancer, Johns Hopkins Kimmel Cancer Center scientists have identified a genetic pathway that acts as a master... Read More
GRU launches special Initiative to reduce the burden of preventable cancers in Georgia
Feb 25, 2015
The Georgia Regents University Cancer Center has launched an initiative seeking to reduce the burden of cancer among minority and underserved populations in Georgia. Read More
FDA approves Farydak for treatment of multiple myeloma
Feb 25, 2015
The U.S. Food and Drug Administration has approved Farydak (panobinostat) for the treatment of patients with multiple myeloma. Read More
Open access to large cancer datasets is critical to clinical advances
Feb 25, 2015
A major challenge facing cancer researchers is the identification and treatment of drug resistant cancers. Read More
FDA approves Farydak for treatment of multiple myeloma
Feb 25, 2015
The U.S. Food and Drug Administration has approved Farydak (panobinostat) for the treatment of patients with multiple myeloma. Read More
Previous Page Next Page